These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19078249)

  • 1. Antimalarials Is Re-evaluation Needed?
    Rynes RI
    J Clin Rheumatol; 1998 Apr; 4(2):50-1. PubMed ID: 19078249
    [No Abstract]   [Full Text] [Related]  

  • 2. Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
    Katz SJ; Russell AS
    Curr Opin Rheumatol; 2011 May; 23(3):278-81. PubMed ID: 21448012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: "Re: Diagnostic Accuracy of Global Pharma Health Fund Minilab
    Pan H; Ba-Thein W
    Am J Trop Med Hyg; 2018 Jun; 98(6):1881. PubMed ID: 29877173
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Monitoring patients on antimalarials: where are we now?
    Freund PR; MacDonald IM
    Can J Ophthalmol; 2013 Jun; 48(3):218. PubMed ID: 23769787
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: monitoring patients on antimalarials: where are we now? Author reply.
    Easterbrook M
    Can J Ophthalmol; 2013 Aug; 48(4):344. PubMed ID: 23931479
    [No Abstract]   [Full Text] [Related]  

  • 6. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma.
    Hodel EM; Zanolari B; Mercier T; Biollaz J; Keiser J; Olliaro P; Genton B; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):867-86. PubMed ID: 19249251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials.
    Gemma S; Campiani G; Butini S; Joshi BP; Kukreja G; Coccone SS; Bernetti M; Persico M; Nacci V; Fiorini I; Novellino E; Taramelli D; Basilico N; Parapini S; Yardley V; Croft S; Keller-Maerki S; Rottmann M; Brun R; Coletta M; Marini S; Guiso G; Caccia S; Fattorusso C
    J Med Chem; 2009 Jan; 52(2):502-13. PubMed ID: 19113955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WIPO re:search: catalyzing collaborations to accelerate product development for diseases of poverty.
    Ramamoorthi R; Graef KM; Krattiger A; Dent JC
    Chem Rev; 2014 Nov; 114(22):11272-9. PubMed ID: 25229276
    [No Abstract]   [Full Text] [Related]  

  • 10. An evaluation of antimalarials with Plasmodium lophurae in the chick.
    REILLY J; CHEN G; GEILING EM
    J Infect Dis; 1949; 85(3):205-12. PubMed ID: 15392980
    [No Abstract]   [Full Text] [Related]  

  • 11. Triggered psoriasis.
    Wolf R; Ruocco V
    Adv Exp Med Biol; 1999; 455():221-5. PubMed ID: 10599347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of antimalarials for rheumatoid arthritis].
    NOVA F
    Hospital (Rio J); 1962 Oct; 62():725-37. PubMed ID: 13939082
    [No Abstract]   [Full Text] [Related]  

  • 13. Syntheses of 9-acridine- and 2-phenanthridinemethanols as potential antimalarials.
    Muth CW; Minigh HL; Chookruvong S; Hall LA; Chao HT
    J Med Chem; 1981 Aug; 24(8):1016-8. PubMed ID: 7035667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chemotherapy in malaria control through primary health care: constraints and future prospects.
    Jeffery GM
    Bull World Health Organ; 1984; 62 Suppl(Suppl):49-53. PubMed ID: 6335682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials.
    Vallières C; Avery SV
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview: clinical pharmacology of antimalarials.
    Karbwang J; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():95-109. PubMed ID: 1364873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is enough enough? The need for a robust pipeline of high-quality antimalarials.
    Wells TN; Poll EM
    Discov Med; 2010 May; 9(48):389-98. PubMed ID: 20515606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of modulators in Plasmodium falciparum resistance to antimalarials].
    Verdier F; Pussard E
    Med Trop (Mars); 1995; 55(4 Suppl):27-32. PubMed ID: 8649262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
    Mavoko HM; Nabasumba C; da Luz RI; Tinto H; D'Alessandro U; Kambugu A; Baraka V; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP
    Lancet Glob Health; 2017 Jan; 5(1):e60-e68. PubMed ID: 27840069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
    Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.